Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-08-10Clinical Trial Update: Enzastaurin in Combination of Capecitabine to Treat Breast Cancer [Phase 2]
Phase 2 trial of enzastaurin in combination with capecitabine for breast cancer was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-08-10Clinical Trial Update: Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer [Phase 2]
Phase 2 trial comparing radium-223 dichloride to placebo with hormonal therapy in bone-predominant HER2-negative, hormone receptor-positive …
-
CLINICAL_TRIALS trial_result · 2020-08-06Clinical Trial Update: Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto) [Phase 3]
Phase 3 trial comparing nanoparticle-based paclitaxel to solvent-based paclitaxel as part of neoadjuvant chemotherapy in early breast cancer…
-
CLINICAL_TRIALS trial_result · 2020-08-06Clinical Trial Update: Mechanistic Study of Duloxetine in Breast Cancer Patients With Chronic Pain [Phase 2]
Phase 2 mechanistic study of duloxetine in breast cancer patients with chronic pain has completed and results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-05Clinical Trial Update: AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer [Phase 2]
A Phase 2 clinical trial comparing AT versus TP as neoadjuvant chemotherapy for HER2-negative early breast cancer is ongoing, with current s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa [Phase 2]
A Phase 2 trial in breast cancer comparing cisplatin to the doxorubicin/cyclophosphamide regimen has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Trastuzumab in Treating Older Women With Early-Stage Breast Cancer [Phase 2]
Phase 2 trial update of trastuzumab in older women with early-stage breast cancer; results have been posted.
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer [Phase 3]
Phase 3 trial examining docetaxel and trastuzumab with or without carboplatin in HER2-positive breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Paclitaxel, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel, trastuzumab, and pertuzumab for metastatic HER2-positive breast cancer completed with posted results in…
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Preoperative Use of Tocotrienol From Annatto Bixa Orellana L. in Breast Cancer Patients: a Prospective Clinical Trial. [Phase 2]
A Phase 2 clinical trial evaluated preoperative tocotrienol from annatto in breast cancer patients and has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-30Clinical Trial Update: Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating GnRH agonist leuprorelin plus letrozole, with or without everolimus, in premenopausal women with metastatic breast …
-
CLINICAL_TRIALS trial_result · 2020-07-29Clinical Trial Update: Anlotinib in Metastatic HER2 Negative Breast Cancer [Phase 2]
Phase 2 clinical trial update for anlotinib in metastatic HER2-negative breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: Post-Mastectomy Analgesia Using Exparel (Liposomal) Versus Standard Bupivacaine or Placebo [Phase 2]
Phase 2 clinical trial update comparing liposomal bupivacaine (Exparel) for post-mastectomy analgesia against standard bupivacaine or placeb…
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ or Invasive Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating radiation therapy after lumpectomy in women with ductal carcinoma in situ or invasive breast cancer has co…
-
CLINICAL_TRIALS trial_result · 2020-07-24Clinical Trial Update: Erector Spinae Versus Paravertebral Nerve Blocks for Breast Surgery [Phase 4]
Phase 4 trial comparing erector spinae versus paravertebral nerve blocks for breast surgery has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-24Clinical Trial Update: Epirubicin in Treating Women Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating epirubicin in women undergoing surgery for Stage I-III breast cancer.
-
CLINICAL_TRIALS trial_result · 2020-07-23Clinical Trial Update: Eribulin Mesylate in Treating Patients With Previously Treated Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating eribulin mesylate in patients with previously treated metastatic breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-20Clinical Trial Update: A Study of DC-CIK Immunotherapy in the Treatment of Solid Tumors [Phase 2]
Phase 2 clinical trial update for DC-CIK immunotherapy in solid tumors; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2020-07-20Clinical Trial Update: Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering Contralateral Prophylactic Mastectomy [NA]
Clinical trial update on a web-based decision aid intended to improve informed decisions for patients with early-stage breast cancer conside…
-
CLINICAL_TRIALS trial_result · 2020-07-15Clinical Trial Update: Trastuzumab Combined With Chemotherapy or Endocrine Therapy to Treat Metastatic Luminal B2 Breast Cancer [Phase 3]
A Phase 3 trial evaluating trastuzumab with either chemotherapy or endocrine therapy for metastatic Luminal B2 breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-15Clinical Trial Update: A Multi-Center Study of Lapatinib in Patients With Trastuzumab-refractory Metastatic Breast Cancer [Phase 2]
A phase 2 multi-center study evaluating lapatinib in patients with trastuzumab-refractory metastatic HER2-positive breast cancer has complet…
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Eribulin Plus Gemcitabine (EG) vs Paclitaxel Plus Gemcitabine (PG) in HER2-Negative Metastatic Breast Cancer [Phase 2]
Phase 2 trial comparing eribulin plus gemcitabine vs paclitaxel plus gemcitabine in HER2-negative metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: 2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer [Phase 2]
Phase 2 trial evaluating pemetrexed plus sorafenib for recurrent or metastatic triple negative breast cancer has been terminated with result…
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Simultaneous Integrated Boost With Volumetric Arc Radiotherapy in Patients With Breast Cancer [Phase 2]
Phase 2 trial evaluating simultaneous integrated boost with volumetric arc radiotherapy in breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-13Clinical Trial Update: Pembrolizumab and Capecitabine in Treating Patients With Locally Advanced or Metastatic Triple Negative or Hormone-Refractory Breast Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating pembrolizumab with capecitabine for locally advanced or metastatic triple-negative breast cancer or hormone-refract…